2016
DOI: 10.5604/16652681.1184233
|View full text |Cite
|
Sign up to set email alerts
|

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
35
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(37 citation statements)
references
References 25 publications
1
35
1
Order By: Relevance
“…AFP is commonly used to diagnose and monitor HCC patients’ conditions after surgery [26], but its role in early dignosis and predicting prognosis of HCC were still in debate, especially some HCC patients were still AFP-negative, so AFP still had some limitations as an screening or predictive indicator. Satellite lesions indicate the cancer is not confined to one site and has disseminated in the liver [27]; encapsulation help limit the tumor in a separate enclosure and prevent it from spreading [28]; BCLC stage 0 + A [29] is common early HCC assessments. These factors were considered to be recurrence related, and the negative condition of them had low indices of clinical suspicion.…”
Section: Discussionmentioning
confidence: 99%
“…AFP is commonly used to diagnose and monitor HCC patients’ conditions after surgery [26], but its role in early dignosis and predicting prognosis of HCC were still in debate, especially some HCC patients were still AFP-negative, so AFP still had some limitations as an screening or predictive indicator. Satellite lesions indicate the cancer is not confined to one site and has disseminated in the liver [27]; encapsulation help limit the tumor in a separate enclosure and prevent it from spreading [28]; BCLC stage 0 + A [29] is common early HCC assessments. These factors were considered to be recurrence related, and the negative condition of them had low indices of clinical suspicion.…”
Section: Discussionmentioning
confidence: 99%
“…Data were taken from 240 patients who had entered the Bern HCC cohort, a prospective cohort, since August 1, 2010 . For inclusion into the Bern cohort, patients had to be >18 years old and were included in the cohort for ≤12 months after first diagnosis.…”
Section: Methodsmentioning
confidence: 99%
“…Data were taken from 240 patients who had entered the Bern HCC cohort, a prospective cohort, since August 1, 2010. 18,19 For inclusion into the Bern cohort, patients had to be >18 years old and were in- Cumulative survival rates were calculated by the Kaplan-Meier method and survival curves were compared by the log-rank test. Cox proportional hazard regressions were used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs).…”
Section: Methodsmentioning
confidence: 99%
“…The BCLC staging system takes tumor stage, liver function, and physical status into account, and this system had been widely adopted for HCC staging and treatment (54). Moreover, the BCLC staging system is the only staging system that assigns treatment strategies based on specific prognostic subclasses, an approach that has proven effective (55).…”
Section: Treatment Criteria Based On the Bclc Staging Systemmentioning
confidence: 99%